As of 2026-09-25, the Relative Valuation of Alliance Pharma PLC (APH.L) is (20.97) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 64.70 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -132.4%.
The range of the Relative Valuation is (19.39) - (25.47) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 13.1x | 9.9x |
| Forward P/E multiples | 9.9x - 14.5x | 11.6x |
| Fair Price | (19.39) - (25.47) | (20.97) |
| Upside | -130.0% - -139.4% | -132.4% |
| Date | P/E |